Leadership at the Centers for Medicare and Medicaid Services is working with states to develop plans to use the $50 billion ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

In an exclusive interview with Yahoo Finance's Decoding Retirement podcast, Mehmet Oz, the administrator of the Centers for ...

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so.

Dr. Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services, discusses the Trump administration’s efforts to eradicate Medicare and Medicaid fraud and build a digital health ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

The latest public gaffe came as the Trump administration is encouraging millions of Americans to transfer their personal ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

President Donald Trump looked as though he was on the verge of falling asleep as a key member of his administration helped ...

The Trump administration is considering a shift in health care coverage, allowing Medicare and Medicaid to cover GLP-1 weight loss drugs.

Dr. Mehmet Oz is the administrator of the Centers for Medicare & Medicaid Services. Kim Brandt is the deputy administrator and chief operating officer.